Endothelial dysfunction: Its clinical value and methods of assessment

Current Atherosclerosis Reports

Volumn 16, Issue 6, 2014, Pages

  Strisciuglio, Teresa ^a   De Luca, Stefania ^a   Capuano, Ernesto ^a   Luciano, Rossella ^a   Niglio, Tullio ^a   Trimarco, Bruno ^a   Galasso, Gennaro ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Coronary artery disease; Endothelial dysfunction; Flow mediated dilation; Pulse amplitude tonometry

Indexed keywords

CELL ADHESION MOLECULE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CORONARY STENT; DISEASE SEVERITY; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; EVEROLIMUS ELUTING STENT; GLYCOCALYX; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SIROLIMUS ELUTING STENT; TONOMETRY; UMIROLIMUS ELUTING STENT; VEIN OCCLUSION PLETHYSMOGRAPHY; ZOTAROLIMUS ELUTING STENT; CARDIOVASCULAR DISEASES; MANOMETRY; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; PROCEDURES; VASCULAR ENDOTHELIUM;

CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; ENDOTHELIUM, VASCULAR; HUMANS; MANOMETRY; PLETHYSMOGRAPHY;

EID: 84901197741     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-014-0417-1     Document Type: Review

References (51)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84(24):9265-9.
2. Drexler H. Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res. 1999;43(3):572-9. (Pubitemid 29369256)
3. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88(11):4651-5. (Pubitemid 21914599)
4. Michelson AD, Benoit SE, Furman MI, Breckwoldt WL, Rohrer MJ, Barnard MR, et al. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol. 1996;270(5 Pt 2):H1640-8.
5. Stamler JS, Lamas S, Fang FC. Nitrosylation. The prototypic redox-based signaling mechanism. Cell. 2001;106(6):675-8.
6. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987;92(1):181-7. (Pubitemid 17134934)
7. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smoothmuscle by acetylcholine. Nature. 1980;288(5789):373-6. (Pubitemid 11169009)
8. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984;54(6):711-8. (Pubitemid 14091676)
9. Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, De Luca G, et al. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation. 2005;111(3):288-94. (Pubitemid 40165334)
10. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III27-32. (Pubitemid 38786440)
11. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83(2):391-401.
12. •• Gargiulo P, Marciano C, Savarese G, D'Amore C, Paolillo S, Esposito G, et al. Endothelial dysfunction in type 2 diabetic patients with normal coronary arteries: a digital reactive hyperemia study. Int J Cardiol. 2013;165(1):67-71. This study demonstrated that diabetes could impair coronary endothelial dysfunction before atherosclerosis development and progression. These results have been obtained trough the EndoPAT method
13. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830-40.
14. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59:655-62.
15. Lamendola P, Lanza GA, Spinelli A, Sgueglia GA, Di Monaco A, Barone L, et al. Long-term prognosis of patients with cardiac syndrome X. Int J Cardiol. 2010;140(2):197-9.
16. • Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2013 Dec 23. This review widely considers all types of endothelial dysfunction and its underlying mechanisms.
17. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111(3):363-8. (Pubitemid 40165345)
18. Galasso G, Schiekofer S, D'Anna C, Gioia GD, Piccolo R, Niglio T, et al. No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives. Angiology. 2014;65(3):180-9.
19. Muller O, Hamilos M, Bartunek J, Ulrichts H, Mangiacapra F, Holz JB, et al. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention. Am J Cardiol. 2010;105(3):333-8.
20. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation. 2005;111(1):70-5. (Pubitemid 40070846)
21. Hamilos M, Sarma J, OstojicM, Cuisset T, Sarno G, Melikian N, et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv. 2008;1(3):193-200.
22. • Galasso G, De Rosa R, Ciccarelli M, Sorriento D, Del Giudice C, Strisciuglio T, et al. β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis. Circ Res. 2013;112(7):1026-34. This article provides new insights of the biology and functions of EPCs.
23. Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol. 2001;52(6):631-46. (Pubitemid 34015621)
24. Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. J Am Coll Cardiol. 2010;3:623-40.
25. Hamada S, Nishiue T, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, et al. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol. 2001;38(3):666-71. (Pubitemid 32835733)
26. Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, et al.Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107(16):2115-9. (Pubitemid 36532193)
27. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Cahrbonneam F, Creager MA, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257-65. (Pubitemid 34084631)
28. Pellegrino T, Storto G, Filardi PP, Sorrentino AR, Silvestro A, Petretta M, et al. Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with diabetes could impair coronary endothelial dysfunction before atherosclerosis development and progression. These results have been obtained trough the EndoPAT method peripheral artery disease. J Nucl Med. 2005;46(12):1997-2002.
29. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108(17):2093-8. (Pubitemid 37337585)
30. Perrone-Filardi P, Cuocolo A, Brevetti G, Silvestro A, Storto G, Dellegrottaglie S, et al. Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol. 2005;96(9):1337-41. (Pubitemid 41505421)
31. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 1995;92(12):3431-5.
32. Bots ML, Westerink J, Rabelink TJ, de Koning EJ. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J. 2005;26(4):363-8. (Pubitemid 40283095)
33. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol. 2002;39(4):683-8. (Pubitemid 34158166)
34. McVeigh GE, Bratteli CW, Morgan DJ, et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis. Hypertension. 1999;33:1392-8. (Pubitemid 29282660)
35. McVeigh GE, Brennan G, Hayes R, Cohn J, Finklestein S, Johnston D. Vascular abnormalities in non-insulin dependent diabetes mellitus identified by arterial waveform analysis. Am J Med. 1993;95:424-30. (Pubitemid 23303073)
36. Celermajer DS. Reliable endothelial function testing: at our fingertips? Circulation. 2008;117(19):2428-30. (Pubitemid 351670447)
37. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol. 2006;101(2):545-8. (Pubitemid 44162364)
38. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117(19):2467-74. (Pubitemid 351670453)
39. Bonetti PO, Pumper GM, Higano ST, Holmes Jr DR, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44(11):2137-41. (Pubitemid 39576032)
40. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31(9):1142-8.
41. Moerland M, Kales AJ, Schrier L, van Dongen MG, Bradnock D, Burggraaf J. Evaluation of the EndoPAT as a Tool to Assess Endothelial Function. Int J Vasc Med. 2012;2012:904141.
42. Noble MI, Drake-Holland AJ, Vink H. Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process. QJM. 2008;101(7):513-8. (Pubitemid 351911993)
43. Constantinescu AA, Vink H, Spaan JA. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol. 2003;23:1541-7. (Pubitemid 37108195)
44. Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer. Circulation. 2000;101:1500-5.
45. Koo A, Dewey Jr CF, García-Cardeña G. Hemodynamic shear stress characteristic of atherosclerosis-resistant regions promotes glycocalyx formation in cultured endothelial cells. Am J Physiol Cell Physiol. 2013;304(2):C137-46.
46. Puri R, Leong DP, Nicholls SJ, Liew GY, Nelson AJ, Carbone A, et al. Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease. EuroIntervention. 2014 Jan 15.
47. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006;55(2):480-6. (Pubitemid 43343279)
48. Bulut D, Maier K, Bulut-Streich N, Börgel J, Hanefeld C, Mügge A. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail. 2008;14(4):336-40. (Pubitemid 351636235)
49. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J. 2003;145(6):962-70. (Pubitemid 36688245)
50. Feng B, Chen Y, Luo Y, Chen M, Li X, Ni Y. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis. 2010;208(1):264-9.
51. Bulut D, Tüns H, Mügge A. CD31+/Annexin V + microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest. 2009;39(1):17-22.